Search clinical trials for: Afirma GSC

Total 2130 results

Riyadh Colleges of Dentistry and Pharmacy

Completed

Grape Seeds Extract Gel as an Adjunct for the Treatment of Chronic Periodontitis

Chronic Periodontitis

Saudi Arabia
Clinical Nutrition Research Center, Illinois Institute...

Completed

Dose-dependent Effect of Grape Seed Extract on Glucose Control in People With Impaired Glucose Tolerance (GSE3)

Impaired Glucose Tolerance

United States
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb; National Cancer Institute (NCI); Medarex

Completed

Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558

Melanoma (Skin)

United States
M.D. Anderson Cancer Center
HiberCell, Inc.

Recruiting

Phase I Study of HC-7366 With Azacitidine and Venetoclax for Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
Anterogen Co., Ltd.

Recruiting

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-302 Clinical Trial

Diabetic Foot Ulcer

Korea, Republic of
Masonic Cancer Center, University of Minnesota

Recruiting

MT2022-01: MSCs for ALD

Cerebral Adrenoleukodystrophy

United States
Mayo Clinic

Recruiting

Allogeneic BM-MSC's in Patients With Lumbar Facet Arthropathy

Facet-Mediated Low Back Pain

United States
Anterogen Co., Ltd.

Recruiting

Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa

Dystrophic Epidermolysis Bullosa

United States
BGI-research
Shenzhen Children's Hospital

Not yet recruiting

Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients

β-Thalassemia Major

China
Anterogen Co., Ltd.

Recruiting

Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.

Diabetic Foot Ulcer

Korea, Republic of
Larkin Community Hospital

Withdrawn

Impact of GSE and Xylitol (Xlear) on COVID-19 Symptoms and Time to PCR Negativisation in COVID-19 Patients

Covid19

United States
Anterogen Co., Ltd.

Completed

A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-301 Clinical Trial

Diabetic Foot Ulcer

Korea, Republic of
Genentech, Inc.

Completed

A Study of GDC-0941 in Participants With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable

Solid Cancers

United States
Oslo University Hospital

Completed

FIRM as a Stand-alone Procedure in the Treatment of Atrial Fibrillation

Atrial Fibrillation

Norway
Genentech, Inc.

Withdrawn

A Study to Assess the Relative Bioavailability And Food Effect of a Tablet Formulation of GDC-0276 in Healthy Participants

Healthy Volunteer

United Kingdom
Glenmark Specialty S.A.

Recruiting

A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas.

Lymphoma | Advanced Solid Tumor

United States, India
Mayo Clinic
Regenerative Medicine Minnesota

Terminated

Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Diabetic Kidney Disease | Diabetic Nephropathies | Chronic Kidney Disease | Kidney Failure | Diabetic Nephropathy Type 2 | Kidney Insufficiency

United States
Memorial Sloan Kettering Cancer Center

Completed

Person-Centered Oncology Care and Choices (P-COCC): Piloting and Initial Randomized Testing of a Combined Values Narrative Interview and Video Education Advance Care Planning Program in Gastrointestinal Oncology Patients

Advanced Gastrointestinal Cancer

United States
University of Chile
Bill and Melinda Gates Foundation

Unknown

Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine (IPV002ABMG)

Polio

Chile
Institut Pasteur
Centre Pasteur du Cameroun; Cameroon Society of Epidemiology (CaSE); Centre International... and other collaborators

Completed

Evaluation of Anti-venoms Serum in Africa (ESAA)

Snake Bites | Antivenins | Snake Venoms

Cameroon
Yung Shin Pharm. Ind. Co., Ltd.
Taichung Veterans General Hospital

Completed

Pharmacokinetics of Two Formulations of Entecavir

Hepatitis B
Vinmec Research Institute of Stem Cell and Gene...

Recruiting

Stem Cell Infusion in the Treatment of Patients With Neurological Complications After Ischemic Stroke

Ischemic Stroke

Vietnam
GeneScience Pharmaceuticals Co., Ltd.

Completed

GS3-007a Oral Solution in Healthy Subjects

Healthy Subject

China
Joshua M Hare
National Heart, Lung, and Blood Institute (NHLBI); The Emmes Company, LLC; Johns...

Terminated

Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) (PROMETHEUS)

Stem Cell Transplantation | Ventricular Dysfunction, Left

United States
Brainstorm-Cell Therapeutics
Hadassah Medical Organization

Completed

Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients.

Amyotrophic Lateral Sclerosis

Israel
Glenmark Specialty S.A.

Completed

Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR) (GSP 301-303)

Perennial Allergic Rhinitis

United States
Assistance Publique - Hôpitaux de Paris

Recruiting

Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy (PRISME)

Pelvic Radiation Therapy | Radiation-induced Hemorrhagic Cystitis

France
LaTonya J. Hickson

Active, not recruiting

Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease

Chronic Kidney Diseases

United States
Third Affiliated Hospital, Sun Yat-Sen University

Withdrawn

MSC-EV in Acute-on-Chronic Liver Failure After Liver Transplantation

Liver Failure, Acute on Chronic

China
Bioinova, s.r.o.
Department of Neurology, University Hospital Motol, Prague, Czech Republic

Terminated

Utilization of AMSC to Enhance Rotator Cuff Repair - Safety and Efficacy (AMSC-RC-001)

Rotator Cuff Tear
Bastyr University
National Center for Complementary and Integrative Health (NCCIH)

Completed

Intranasal Glutathione in Parkinson's Disease

Parkinson's Disease (PD)

United States
GlaxoSmithKline

Completed

GSK BHR Study (Sont)

Asthma

United States, Latvia, Puerto Rico, Brazil
Universidade Nova de Lisboa
University Hospital, Geneva; NOVA Medical School; Administração Regional de Saúde... and other collaborators

Not yet recruiting

Multimorbidity Management Supported by a Digital Platform

Chronic Disease
LaTonya J. Hickson

Active, not recruiting

Stem Cell Therapy for Chronic Kidney Disease

Diabetes Mellitus, Type 2 | Diabetes Mellitus | Chronic Kidney Diseases | Diabetes Mellitus, Type 1 | Diabetic Nephropathies

United States
University of Bergen
Haukeland University Hospital; University of Ulm; Université de Nantes

Completed

Reconstruction of Jaw Bone Using Mesenchymal Stem Cells

Bone Atrophy

Norway
Genmedica Therapeutics S.L.
Simbec Research

Terminated

Multiple Ascending Dose Study of GMC-252-L-Lys Salt in Healthy Subjects and Type 2 Diabetics

Healthy | Type 2 Diabetes Mellitus

United Kingdom
Joanne Kurtzberg, MD
The Marcus Foundation

Terminated

hCT-MSCs for COVID19 ARDS

COVID | Corona Virus Infection | COVID19

United States
gicare Pharma Inc.
Algorithme Pharma Inc

Completed

Study on Analgesia of GIC-1001 & GIC-1002 on Visceral Pain, Rectal Sensory Threshold Using the Barostat Method

Pain | Cancer | Colonic Disease

Canada
Sichuan Baili Pharmaceutical Co., Ltd.

Recruiting

A Study of GNC-035 in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematological Malignancies

Relapsed/Refractory Chronic Lymphocytic Leukemia

China
University Hospital, Tours

Not yet recruiting

Skin-to-skin Contact During the Transfer From the Delivery Room to the Neonatal Intensive Care Unit: Impact on Very Preterm Infants and Their Parents (TRANSPAPNEO)

Premature Newborns | Skin to Skin

France
Sichuan Baili Pharmaceutical Co., Ltd.
SystImmune Inc.

Recruiting

Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia | Non Hodgkin Lymphoma

China
The University of Queensland
Isopogen; Cell and Tissue Therapies

Completed

Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction (ASSIST-CLAD)

Chronic Lung Allograft Dysfunction (CLAD)

Australia
Banc de Sang i Teixits

Completed

Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19 (COVIDMES)

COVID-19 | SARS-CoV 2 | Adult Respiratory Distress Syndrome

Spain
Hoffmann-La Roche

Completed

Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Participants With Previously Treated Solid Tumors (iMATRIXcobi)

Solid Tumors

United States, Spain, Germany, France, Israel, Italy, United Kingdom
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches

Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma

United States, Canada
Icahn School of Medicine at Mount Sinai
Patient-Centered Outcomes Research Institute

Completed

Improving Goals of Care Discussion in Advanced Cancer Patients

Melanoma | Glioblastoma | Colorectal Cancer | Cancer of Pancreas | Cancer of Stomach | Head or Neck Cancer | Stage III | Esophageal | Stage IV | Lung Cancers | Pancreatic Cancers | Primary Stage IV Hepatobiliary

United States
Fuda Cancer Hospital, Guangzhou
University of Michigan

Completed

Safety and Effectivity Immunotherapy to Treat Ovarian Cancer With Cancer Stem Cells Vaccine

Neoplasms,Ovarian

China
University Medical Centre Ljubljana
Slovenian Research Agency

Terminated

Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Antibody Mediated Kidney Graft Rejection (ABMR)

Interventional

Slovenia
University Hospital Plymouth NHS Trust

Completed

Cardiac GSI Feasibility Study

High Risk of Significant Coronary Artery Disease

United Kingdom
La Jolla Pharmaceutical Company

Withdrawn

A Phase 2 Extension of Study GCS-100-CS-4003

Chronic Kidney Disease

United States

Search clinical trials for: Afirma GSC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations